Jun Young Sonn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jun Young Sonn has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ali Shilatifard
Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine
1 shared publication Guantong Qi
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
1 shared publication- Huda Yahya Zoghbi
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX
1 shared publication - Ismael Al-Ramahi
Baylor College of Medicine
1 shared publication - Janice L. Brissette
Department of Cell Biology State University of New York Downstate Health Sciences University Brooklyn NY USA
1 shared publication - Juan Botas
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA
1 shared publication
Latest Publications
- Open Access
- 28 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (48) , eadt5937
MeCP2 interacts with the super elongation complex to regulate transcription
Loss-of-function mutations in methyl-CpG binding protein 2 ( MECP2 ) cause Rett syndrome. While we know that MeCP2 binds to methylated cytosines on DNA, the full breadth of the molecular mechanisms by which MeCP2 regulates gene expression remains incompletely understood. Here, using a genetic modifier screen, we identify the super elongation complex, a P-TEFb–containing elongation factor that releases promoter-proximally paused RNA polymerase II, as a genetic interactor of MECP2 . MeCP2 physically interacts with SEC subunits and directly binds AFF4, the scaffold of the SEC, via the transcriptional repression domain. Furthermore, MeCP2 facilitates the binding of AFF4 on a subset of genes in the mouse brain regulating synaptic plasticity and concordantly promotes the binding of RNA polymerase II on these genes. Last, while haploinsufficiency of Aff4 does not exhibit any behavioral deficits in mice, it exacerbates the impaired contextual learning behavior of Mecp2 hypomorphic mice. We propose a previously unknown mechanism by which MePC2 regulates gene expression underlying synaptic plasticity.
- 28 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (48) , eadt5937
Open AccessMeCP2 interacts with the super elongation complex to regulate transcription
Loss-of-function mutations in methyl-CpG binding protein 2 ( MECP2 ) cause Rett syndrome. While we know that MeCP2 binds to methylated cytosines on DNA, the full breadth of the molecular mechanisms by which MeCP2 regulates gene expression remains incompletely understood. Here, using a genetic modifier screen, we identify the super elongation complex, a P-TEFb–containing elongation factor that releases promoter-proximally paused RNA polymerase II, as a genetic interactor of MECP2 . MeCP2 physically interacts with SEC subunits and directly binds AFF4, the scaffold of the SEC, via the transcriptional repression domain. Furthermore, MeCP2 facilitates the binding of AFF4 on a subset of genes in the mouse brain regulating synaptic plasticity and concordantly promotes the binding of RNA polymerase II on these genes. Last, while haploinsufficiency of Aff4 does not exhibit any behavioral deficits in mice, it exacerbates the impaired contextual learning behavior of Mecp2 hypomorphic mice. We propose a previously unknown mechanism by which MePC2 regulates gene expression underlying synaptic plasticity.